Advertisement
Screener

NU SKIN ENTERPRISES, INC. (NUS) Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

1.4 / 5 stars · 34/118 Roast Me

NU SKIN ENTERPRISES, INC. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

NU SKIN ENTERPRISES, INC. (NUS) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-08-10

  • NU SKIN ENTERPRISES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2026-06-30 was $0.00.
  • NU SKIN ENTERPRISES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
  • NU SKIN ENTERPRISES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-12-31 was $0.00.
  • NU SKIN ENTERPRISES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-09-30 was $0.00.
  • NU SKIN ENTERPRISES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2025 was $28.08M.
  • NU SKIN ENTERPRISES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2024 was $0.00.
  • NU SKIN ENTERPRISES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2023 was $0.00.
Period endEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
$0.00
10-Q · filed 2026-08-10
$0.00
derived: sum of 3 quarters · filed 2026-08-10
$0.00
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31$0.00
10-Q · filed 2026-05-08
$0.00
derived: sum of 2 quarters · filed 2026-05-08
$0.00
derived: sum of 3 quarters · filed 2026-05-08
$0.00
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$0.00
derived: sum of 2 quarters · filed 2026-02-13
$0.00
derived: sum of 3 quarters · filed 2026-08-10
$28.08M
10-K · filed 2026-02-13
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$0.00
derived: sum of 2 quarters · filed 2026-08-10
$28.08M
10-Q · filed 2025-11-07
$28.08M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
$28.08M
10-Q · filed 2026-08-10
$28.08M
derived: sum of 3 quarters · filed 2026-08-10
$28.08M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$28.08M
10-Q · filed 2026-05-08
$28.08M
derived: sum of 2 quarters · filed 2026-05-08
$28.08M
derived: sum of 3 quarters · filed 2026-05-08
$28.08M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$0.00
derived: sum of 2 quarters · filed 2026-02-13
$0.00
derived: sum of 3 quarters · filed 2026-02-13
$0.00
10-K · filed 2026-02-13
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$0.00
derived: sum of 2 quarters · filed 2025-11-07
$0.00
10-Q · filed 2025-11-07
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$0.00
10-Q · filed 2025-08-08
2024-03-31$0.00
10-Q · filed 2025-05-09
2023-12-31$0.00
10-K · filed 2026-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
HWH International Inc. (HWH)United States$0.021B-4.08
DataMeds AI, Inc. (MEDS)United States$0.011B
HERBALIFE LTD. (HLF)$1.281B8.39
CARDINAL HEALTH INC (CAH)United States$51.753B29.38
Cencora, Inc. (COR)United States$59.130B20.57
MCKESSON CORP (MCK)United States$101.317B19.78